INY-03-041

1 Cited Publications
고객리뷰

Based on 1 publication(s) in Google Scholar

INY-03-041 is a potent, highly selective and PROTAC-based pan-AKT degrader consisting of the ATP-competitive AKT inhibitor Ipatasertib (HY-15186) conjugated to Lenalidomide (HY-A0003, Cereblon ligand). INY-03-041 inhibits AKT1, AKT2 and AKT3 with IC50s of 2.0, 6.8 and 3.5 nM, respectively.
(Pink: Akt ligand (HY-130988); Blue: Cereblon ligand (HY-43722); Black: linker (HY-130985)).

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity: 99.74%
  • CAS No.: 2503017-97-6
  • 화학식: C44H56ClN7O5
  • 분자량:798.41
  • 보관:

    -20°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biological Activity
  • Chemical Information
  • 용액&용해도
  • 순도&문서
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) INY-03-041

More

All Akt Isoforms

More
100 mg
견적 받기 해외재고보유
Please select quantity
Price: USD 0.00